Please join us for a webinar on June 2, 2015 at 12 pm EDT to discuss our recent paper, “When Does FDAMA Section 114 Apply and How Might It Change? Ten Case Studies”. During the one-hour webinar, we’ll discuss hypothetical situations to explore whether various types of information could be shared by biopharmaceutical companies under current law; potential changes to FDAMA Section 114; and related provisions in the 21st Century Cures Act. By Peter Neumann, ScD, and Cayla Saret, BA.
You are here: / / Case Studies for FDAMA 114